Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Huskamp, H. A. Articles by Keating, N. L. Search for Related Content PubMed Citation Articles by Huskamp, H. A. Articles by Keating, N. L. Health Insurance Atypical Neuroleptics Anticonvulsants Antidepressants Related Article

Economic Grand Rounds: Coverage and Prior Authorization of Psychotropic Drugs Under Medicare Part D

This study examined formulary coverage and use of utilization management tools for three classes of psychotropic medications (antidepressants, antipsychotics, and anticonvulsants) among Medicare Part D prescription drug plans serving individuals dually eligible for the Medicare and Medicaid programs. Plans must cover "all or substantially all" molecules (distinct drugs) in these classes. Plans serving "dual eligibles" generally covered at least one formulation of all molecules in the three classes. However, certain product formulations were not covered by a number of plans, and use of prior authorization was common for a minority of plans. The effect of Part D will depend on the restrictiveness of the prior authorization and appeals processes, which is currently unknown.

Related Article:

March 2007: This Month's Highlights
Psychiatr Serv 2007 58: 299. [Full Text] [PDF]

This article has been cited by other articles:

				H. A. Huskamp, J. C. West, D. S. Rae, M. Rubio-Stipec, D. A. Regier, and R. G. Frank Part D and Dually Eligible Patients With Mental Illness: Medication Access Problems and Use of Intensive Services Psychiatr Serv, September 1, 2009; 60(9): 1169 - 1174. [Abstract] [Full Text] [PDF]

				A. S. Adams, F. Zhang, R. F. LeCates, A. J. Graves, D. Ross-Degnan, D. Gilden, T. J. McLaughlin, C. Lu, C. M. Trinacty, and S. B. Soumerai Prior Authorization for Antidepressants in Medicaid: Effects Among Disabled Dual Enrollees Arch Intern Med, April 27, 2009; 169(8): 750 - 756. [Abstract] [Full Text] [PDF]

				Y. Zhang, A. S. Adams, D. Ross-Degnan, F. Zhang, and S. B. Soumerai Effects of Prior Authorization on Medication Discontinuation Among Medicaid Beneficiaries With Bipolar Disorder Psychiatr Serv, April 1, 2009; 60(4): 520 - 527. [Abstract] [Full Text] [PDF]

				R. A. Rosenheck, D. L. Leslie, and J. A. Doshi Second-Generation Antipsychotics: Cost-Effectiveness, Policy Options, and Political Decision Making Psychiatr Serv, May 1, 2008; 59(5): 515 - 520. [Abstract] [Full Text] [PDF]

				M. R. Law, D. Ross-Degnan, and S. B. Soumerai Effect of Prior Authorization of Second-Generation Antipsychotic Agents on Pharmacy Utilization and Reimbursements Psychiatr Serv, May 1, 2008; 59(5): 540 - 546. [Abstract] [Full Text] [PDF]

				S. B. Soumerai, F. Zhang, D. Ross-Degnan, D. E. Ball, R. F. LeCates, M. R. Law, T. E. Hughes, D. Chapman, and A. S. Adams Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change Health Aff., May 1, 2008; 27(3): w185 - w195. [Abstract] [Full Text] [PDF]

				J. M. Donohue and R. G. Frank Estimating Medicare Part D's Impact on Medication Access Among Dually Eligible Beneficiaries With Mental Disorders Psychiatr Serv, October 1, 2007; 58(10): 1285 - 1291. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us